Natco Pharma has informed that the Board of Directors of the Company at its meeting held on May 28, 2012,has transacted the recommendations of the Remuneration Committee of the Board of Directors, the Board, subject to the approval of members at the ensuing General Meeting, had revised the remuneration payable to V. C. Nannapaneni, Chairman and Managing Director of the Company and redesignated Rajeev Nannapaneni as Vice Chairman & CEO besides increasing his remuneration with effect from June 01, 2012 for a period of three years.
The above information is part of company’s filing submitted to the BSE.
